Logo image
Endometrial cancer
Journal article   Peer reviewed

Endometrial cancer

Kimberly K Leslie, Kristina W Thiel, Michael J Goodheart, Koen De Geest, Yichen Jia and Shujie Yang
Obstetrics and gynecology clinics of North America, Vol.39(2), pp.255-268
06/2012
DOI: 10.1016/j.ogc.2012.04.001
PMCID: PMC3518445
PMID: 22640714
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3518445View
Open Access

Abstract

Despite the questions and barriers, the incorporation of molecular therapy into treatment regimens in endometrial cancer is an exciting area of investigation with the potential to improve outcomes. Outside of the development of a reliable screening test for endometrial cancer, converting the disease to a chronic state and improving progression-free survival is our best hope to reverse the concerning trend of decreasing 5-year survival for this disease.
Lymph Node Excision United States - epidemiology Prognosis Obesity - complications Humans Middle Aged Risk Factors Hysterectomy Endometrial Neoplasms - diagnosis Uterine Hemorrhage - etiology Molecular Targeted Therapy - trends Antineoplastic Combined Chemotherapy Protocols - therapeutic use Endometrial Neoplasms - complications Endometrial Neoplasms - therapy Postmenopause Female Aged Chemotherapy, Adjuvant Molecular Targeted Therapy - methods

Details

Metrics

Logo image